摘要
目的：探讨替米沙坦联合泼尼松治疗特发性肺纤雏化的·临床疗效。方法：选取我院2008年1月－2010年1月收治的60例特发性肺纤维化病人的临床资料，随机分为治疗组（30例）和对照组（30例），对照组病人应用泼尼松治疗，治疗组病人在对照组治疗的基础上加用替米沙坦，连续治疗6个月，比较两组病人的临床疗效。结果：治疗组病人临床症状和肺功能改善优于对照组，两组病人比较差异有统计学意义（p〈0．05）。结论：替米沙坦联合泼尼松治疗肺纤维化，能明显减轻病人的临床症状，改善肺功能，疗效满意值得在临床推广。
Objective：To investigate the telmisartan and prednisone treatment of idiopathic pulmonary fibrosis clinical efficacy. Methods： A hospital in,January 2008--January 2010 were treated 60 cases of idiopathic pulmonary fibrosis patient＇s clinical data, were randomly divided into treatment group （30 cases） and control group （30 cases） ,control group patients treated with prednisone therapy,the treatment group of patients in the control group based on the use of telmisartan, a continuous treatment for 6 months, compared two groups of patients in clinical efficacy. Results：The improvement of clinical symptoms and lung function than the cOntrol group, two groups of patients the difference was statistically significant （p 〈0.05）. Conclusion：Telmisartan and prednisone treatment of pulmonary fibrosis,can significantly reduce the patient＇s clinical symptoms,improve lung funetion,results were satisfactory in clinical promotion.
出处
《按摩与康复医学》
2011年第20期69-70,共2页
Chinese Manipulation and Rehabilitation Medicine
关键词
特发性肺纤维化
泼尼松
替米沙坦
肺功能
临床疗效
Idiopathic pulmonary fibrosis Prednisone Telmisartan Lung function Clinical curative effect
